Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 25 02 2024
accepted: 13 05 2024
medline: 18 5 2024
pubmed: 18 5 2024
entrez: 17 5 2024
Statut: epublish

Résumé

Non-resuscitation fluids constitute the majority of fluid administered for septic shock patients in the intensive care unit (ICU). This multicentre, randomized, feasibility trial was conducted to test the hypothesis that a restrictive protocol targeting non-resuscitation fluids reduces the overall volume administered compared with usual care. Adults with septic shock in six Swedish ICUs were randomized within 12 h of ICU admission to receive either protocolized reduction of non-resuscitation fluids or usual care. The primary outcome was the total volume of fluid administered within three days of inclusion. Median (IQR) total volume of fluid in the first three days, was 6008 ml (interquartile range [IQR] 3960-8123) in the restrictive fluid group (n = 44), and 9765 ml (IQR 6804-12,401) in the control group (n = 48); corresponding to a Hodges-Lehmann median difference of 3560 ml [95% confidence interval 1614-5302]; p < 0.001). Outcome data on all-cause mortality, days alive and free of mechanical ventilation and acute kidney injury or ischemic events in the ICU within 90 days of inclusion were recorded in 98/98 (100%), 95/98 (98%) and 95/98 (98%) of participants respectively. Cognition and health-related quality of life at six months were recorded in 39/52 (75%) and 41/52 (79%) of surviving participants, respectively. Ninety out of 134 patients (67%) of eligible patients were randomized, and 15/98 (15%) of the participants experienced at least one protocol violation. Protocolized reduction of non-resuscitation fluids in patients with septic shock resulted in a large decrease in fluid administration compared with usual care. A trial using this design to test if reducing non-resuscitation fluids improves outcomes is feasible. Clinicaltrials.gov, NCT05249088, 18 February 2022. https://clinicaltrials.gov/ct2/show/NCT05249088.

Sections du résumé

BACKGROUND/PURPOSE OBJECTIVE
Non-resuscitation fluids constitute the majority of fluid administered for septic shock patients in the intensive care unit (ICU). This multicentre, randomized, feasibility trial was conducted to test the hypothesis that a restrictive protocol targeting non-resuscitation fluids reduces the overall volume administered compared with usual care.
METHODS METHODS
Adults with septic shock in six Swedish ICUs were randomized within 12 h of ICU admission to receive either protocolized reduction of non-resuscitation fluids or usual care. The primary outcome was the total volume of fluid administered within three days of inclusion.
RESULTS RESULTS
Median (IQR) total volume of fluid in the first three days, was 6008 ml (interquartile range [IQR] 3960-8123) in the restrictive fluid group (n = 44), and 9765 ml (IQR 6804-12,401) in the control group (n = 48); corresponding to a Hodges-Lehmann median difference of 3560 ml [95% confidence interval 1614-5302]; p < 0.001). Outcome data on all-cause mortality, days alive and free of mechanical ventilation and acute kidney injury or ischemic events in the ICU within 90 days of inclusion were recorded in 98/98 (100%), 95/98 (98%) and 95/98 (98%) of participants respectively. Cognition and health-related quality of life at six months were recorded in 39/52 (75%) and 41/52 (79%) of surviving participants, respectively. Ninety out of 134 patients (67%) of eligible patients were randomized, and 15/98 (15%) of the participants experienced at least one protocol violation.
CONCLUSION CONCLUSIONS
Protocolized reduction of non-resuscitation fluids in patients with septic shock resulted in a large decrease in fluid administration compared with usual care. A trial using this design to test if reducing non-resuscitation fluids improves outcomes is feasible.
TRIAL REGISTRATION BACKGROUND
Clinicaltrials.gov, NCT05249088, 18 February 2022. https://clinicaltrials.gov/ct2/show/NCT05249088.

Identifiants

pubmed: 38760833
doi: 10.1186/s13054-024-04952-w
pii: 10.1186/s13054-024-04952-w
doi:

Banques de données

ClinicalTrials.gov
['NCT05249088']

Types de publication

Journal Article Randomized Controlled Trial Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

166

Subventions

Organisme : Swedish National Health Service
ID : ALF 86626

Investigateurs

Jane Fisher (J)
Maria Nelderup (M)
Lisa Hassel (L)
Eva Johnsson (E)
Camilla Claesson (C)
Anna Lybeck (A)
Susann Schrey (S)
Linda K Andersson (LK)
Sandra Holmström (S)
Marina Larsson (M)
Katarina Bramell (K)
Karin Aspholm (K)
Karin Olne (K)
Hanna Larsson (H)
Miklos Lipscey (M)
Region Skåne (R)
Niklas Nielsen (N)

Informations de copyright

© 2024. The Author(s).

Références

Lindén-Søndersø A, Jungner M, Spångfors M, et al. Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study. Ann Intensive Care. 2019. https://doi.org/10.1186/s13613-019-0607-7 .
doi: 10.1186/s13613-019-0607-7 pubmed: 31776712 pmcid: 6881490
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011. https://doi.org/10.1097/CCM.0b013e3181feeb15 .
doi: 10.1097/CCM.0b013e3181feeb15 pubmed: 21849834 pmcid: 3776416
Sakr Y, Rubatto Birri PN, Kotfis K, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2017. https://doi.org/10.1097/CCM.0000000000002189 .
doi: 10.1097/CCM.0000000000002189 pubmed: 27922878
Silversides JA, Fitzgerald E, Manickavasagam US, et al. Deresuscitation of patients with iatrogenic fluid overload is associated with reduced mortality in critical illness. Crit Care Med. 2018. https://doi.org/10.1097/CCM.0000000000003276 .
doi: 10.1097/CCM.0000000000003276 pubmed: 29985214
Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12:R74.
doi: 10.1186/cc6916 pubmed: 18533029 pmcid: 2481469
Sivapalan P, Ellekjaer KL, Jessen MK, et al. Lower vs higher fluid volumes in adult patients with sepsis: an updated systematic review with meta-analysis and trial sequential analysis. Chest. 2023. https://doi.org/10.1016/j.chest.2023.04.036 .
doi: 10.1016/j.chest.2023.04.036 pubmed: 37574165 pmcid: 10567931
Hjortrup PB, Haase N, Bundgaard H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016. https://doi.org/10.1007/s00134-016-4500-7 .
doi: 10.1007/s00134-016-4500-7 pubmed: 27798738
Lindén A, Fisher J, Lilja G, et al. Protocolized reduction of non-resuscitation fluids in septic shock—A protocol for a multicentre feasibility trial. BMJ Open. 2023. https://doi.org/10.1136/bmjopen-2022-065392 .
doi: 10.1136/bmjopen-2022-065392 pubmed: 38035747 pmcid: 10689398
Olsen M, Lindén A, Lilja G et al. Protocolised REDUction of non-resuscitation fluids versus usual care in SEptic shock patients (REDUSE) - a statistical analysis plan for a multicentre feasibility trial. 2022. https://zenodo.org/records/7392132#.ZGXJVnZBx3g . Accessed 9 November 2023
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016. https://doi.org/10.1001/jama.2016.0287 .
doi: 10.1001/jama.2016.0287 pubmed: 27825007 pmcid: 5433435
DeBacker D, Cecconi M, Chew MS, et al. A plea for personalization of hemodynamic management of septic shock. Crit Care. 2022. https://doi.org/10.1186/s13054-022-04255-y .
doi: 10.1186/s13054-022-04255-y
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intens Care Med. 2021. https://doi.org/10.1007/s00134-021-06506-y .
doi: 10.1007/s00134-021-06506-y
Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; https://doi.org/10.1186/cc11454
Brown SM, Collingridge DS, Wilson EL, et al. Preliminary validation of the Montreal cognitive assessment tool among sepsis survivors: a prospective pilot study. Ann Am Thorac Soc. 2018. https://doi.org/10.1513/AnnalsATS.201804-233OC .
doi: 10.1513/AnnalsATS.201804-233OC pubmed: 30265153 pmcid: 6322022
Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
doi: 10.1111/j.1532-5415.2005.53221.x pubmed: 15817019
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of eq-5d (eq-5d-5l). Quality Life Res. 2011;20:1727–36. https://doi.org/10.1007/s11136-011-9903-x .
doi: 10.1007/s11136-011-9903-x
Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. Neurotrauma. 1998;15(8):573–85.
doi: 10.1089/neu.1998.15.573
Lehmann EL. Nonparametrics. Statistical Methods Based on Ranks, Revised. Prentice Hall 1998. p. 76–81. ISBN:13997735X, 9780139977350.
Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022. https://doi.org/10.1056/NEJMoa2202707 .
doi: 10.1056/NEJMoa2202707 pubmed: 36053521
Kjær MBN, Meyhoff TS, Sivapalan P, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023. https://doi.org/10.1007/s00134-023-07114-8 .
doi: 10.1007/s00134-023-07114-8 pubmed: 37330928 pmcid: 10354110
Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, et al. Hypothermia vs normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2100591 .
doi: 10.1056/NEJMoa2100591 pubmed: 34587397
Hammond NE, Finfer SR, Li Q, Taylor C, et al. Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial. Intensive Care Med. 2020. https://doi.org/10.1007/s00134-020-06169-1 .
doi: 10.1007/s00134-020-06169-1 pubmed: 32676679 pmcid: 7101866
Wilcox ME, Ely EW. Challenges in conducting long-term outcomes studies in critical care. Curr Opin Crit Care. 2019. https://doi.org/10.1097/MCC.0000000000000650 .
doi: 10.1097/MCC.0000000000000650 pubmed: 31356238 pmcid: 7141412
Baigent C, Harrell FE, Buyse M, Emberson JR, Altman DG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008. https://doi.org/10.1177/1740774507087554 .
doi: 10.1177/1740774507087554 pubmed: 18283080
National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical Guideline174. 2017. www.nice.org.uk/guidance/cg174 . Accessed 9 November 2023
Van Regenmortel N, Verbrugghe W, Roelant E. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018. https://doi.org/10.1007/s00134-018-5147-3 .
doi: 10.1007/s00134-018-5147-3 pubmed: 29589054 pmcid: 5924672
Danish Society of Anaesthesiology and Intensive care medicine. Nutrition for the critically ill (in danish). https://dasaim.dk/guides/pdf-nbv-ernaering-til-kritisk-syge-2019 . Accessed 9 November 2023.
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutrit. 2018. https://doi.org/10.1016/j.clnu.2018.08.037 .
doi: 10.1016/j.clnu.2018.08.037
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.). Crit Care Med. 2016. https://doi.org/10.1177/0148607115621863 .
doi: 10.1177/0148607115621863 pubmed: 26771786

Auteurs

Anja Lindén (A)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. anja.linden.icu@gmail.com.
Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhléns Gata 10, 252 23, Helsingborg, Sweden. anja.linden.icu@gmail.com.

M Spångfors (M)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Anesthesiology and Intensive Care, Kristianstad Hospital, Kristianstad, Sweden.

M H Olsen (MH)

Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital -Rigshospitalet, Copenhagen, Denmark.

J Fisher (J)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

G Lilja (G)

Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Neurology Department, Skåne University Hospital, Lund, Sweden.

F Sjövall (F)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skane University Hospital, Malmö, Sweden.

M Jungner (M)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skane University Hospital, Malmö, Sweden.

M Lengquist (M)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skane University Hospital, Lund, Sweden.

T Kander (T)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skane University Hospital, Lund, Sweden.

L Samuelsson (L)

Department of Anesthesiology and Intensive Care, Östersund Hospital, Östersund, Sweden.

J Johansson (J)

Department of Anesthesiology and Intensive Care, Östersund Hospital, Östersund, Sweden.

E Palmnäs (E)

Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.

J Undén (J)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.

J Oras (J)

Department of Anesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

M Cronhjort (M)

Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden.

M Chew (M)

Department of Anesthesiology and Intensive Care, Linköping University Hospital, Linköping, Sweden.

A Linder (A)

Infectious Diseases, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

M Lipcsey (M)

Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

N Nielsen (N)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhléns Gata 10, 252 23, Helsingborg, Sweden.

J C Jakobsen (JC)

Department of Anesthesiology and Intensive Care, Kristianstad Hospital, Kristianstad, Sweden.
Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

P Bentzer (P)

Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhléns Gata 10, 252 23, Helsingborg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH